Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Babbage

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
British Journal of Cancer|June 1, 1982
Increased therapeutic efficiency of a lipid-soluble alkylating agent incorporated in liposomesJ W Babbage, M C Berenbaum
Journal of Immunological Methods|January 1, 1976
A raft technique for chemotaxis: a versatile method suitable for clinical studiesI E Addison, J W Babbage
Journal of Immunological Methods|February 1, 1975
Antibody response by cells cultured on dialysis membrane in disposable plastic vesselsI E Addison, J W Babbage
British Journal of Experimental Pathology|February 1, 1981
Thymus-dependent and thymus-independent antibody responses: contrasting patterns of immunosuppressionI E Addison, J W Babbage
Clinical and Experimental Immunology|May 1, 1985
Defective in vitro antibody production in response to pokeweed mitogen and influenza antigen in patients with Hodgkin's diseaseA Sigfusson, J W Babbage, R L Souhami
Molecular and Cellular Biology|June 22, 1999
p70(s6k) integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytesP Brennan, J W Babbage, G Thomas, et al.
The EMBO Journal|April 15, 1996
Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathwayC Beadling, J Ng, J W Babbage, et al.
Immunity|December 9, 1997
Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2FP Brennan, J W Babbage, B M Burgering, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
British Journal of Cancer|June 1, 1982
Increased therapeutic efficiency of a lipid-soluble alkylating agent incorporated in liposomesJ W Babbage, M C Berenbaum
Journal of Immunological Methods|January 1, 1976
A raft technique for chemotaxis: a versatile method suitable for clinical studiesI E Addison, J W Babbage
Journal of Immunological Methods|February 1, 1975
Antibody response by cells cultured on dialysis membrane in disposable plastic vesselsI E Addison, J W Babbage
British Journal of Experimental Pathology|February 1, 1981
Thymus-dependent and thymus-independent antibody responses: contrasting patterns of immunosuppressionI E Addison, J W Babbage
Clinical and Experimental Immunology|May 1, 1985
Defective in vitro antibody production in response to pokeweed mitogen and influenza antigen in patients with Hodgkin's diseaseA Sigfusson, J W Babbage, R L Souhami
Molecular and Cellular Biology|June 22, 1999
p70(s6k) integrates phosphatidylinositol 3-kinase and rapamycin-regulated signals for E2F regulation in T lymphocytesP Brennan, J W Babbage, G Thomas, et al.
The EMBO Journal|April 15, 1996
Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathwayC Beadling, J Ng, J W Babbage, et al.
Immunity|December 9, 1997
Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2FP Brennan, J W Babbage, B M Burgering, et al.
Pageof 1